Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Mechanistic study of the polyphenol castalagin and its impact on gut microbiota composition and metabolism in the context of cancer immunotherapy

FY 2022-23

Summary
Immunotherapies have revolutionized the treatment of cancer; however, many patients do not respond to these treatments. Patients that respond to immune checkpoint inhibitors (ICIs), a form of immunotherapy, have distinct gut microbiota compositions compared to their non-responder counterparts. Studies in mice have shown that this result is more than a correlation: supplementing non-responder gut bacteria with those enriched in responders could restore sensitivity to ICIs. Therefore, by changing the composition of the gut microbiota, we could improve the response of cancer patients to life-saving immunotherapies. We have identified a dietary polyphenol from the camu-camu berry, called castalagin, that acts through the gut microbiota to render non-responder mice sensitive to ICIs. The main goals of my research project are to understand how castalagin shapes the gut microbiota, which bacteria metabolize it, and what bacteria do with it. We will first use genomic sequencing techniques to assess how castalagin changes the composition and function of the gut microbiota in bioreactors. We will then use community-wide RNA sequencing techniques to map bacteria to specific metabolic steps and identify the enzymes involved in each step. Finally, we will use chemical biology approaches to identify bacteria that physically interact with castalagin and will evaluate the response of bacteria to castalagin exposure by measuring growth, gene expression, and metabolite production. Altogether, our proposed research project will answer basic research questions about dietary polyphenol-microbiota interactions. This project will also advance castalagin in its translation from bench to bedside in the context of cancer immunotherapy.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
475840
Name
Pidgeon Reilly C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Mechanistic study of the polyphenol castalagin and its impact on gut microbiota composition and metabolism in the context of cancer immunotherapy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cancer Research; Chemical Biology; Drug Discovery; Drug Metabolism; Immunology; Mechanism Of Action; Metabolic Pathways; Microbiome Research; Molecular Probes; Polyphenols
Abstract
Immunotherapies have revolutionized the treatment of cancer; however, many patients do not respond to these treatments. Patients that respond to immune checkpoint inhibitors (ICIs), a form of immunotherapy, have distinct gut microbiota compositions compared to their non-responder counterparts. Studies in mice have shown that this result is more than a correlation: supplementing non-responder gut bacteria with those enriched in responders could restore sensitivity to ICIs. Therefore, by changing the composition of the gut microbiota, we could improve the response of cancer patients to life-saving immunotherapies. We have identified a dietary polyphenol from the camu-camu berry, called castalagin, that acts through the gut microbiota to render non-responder mice sensitive to ICIs. The main goals of my research project are to understand how castalagin shapes the gut microbiota, which bacteria metabolize it, and what bacteria do with it. We will first use genomic sequencing techniques to assess how castalagin changes the composition and function of the gut microbiota in bioreactors. We will then use community-wide RNA sequencing techniques to map bacteria to specific metabolic steps and identify the enzymes involved in each step. Finally, we will use chemical biology approaches to identify bacteria that physically interact with castalagin and will evaluate the response of bacteria to castalagin exposure by measuring growth, gene expression, and metabolite production. Altogether, our proposed research project will answer basic research questions about dietary polyphenol-microbiota interactions. This project will also advance castalagin in its translation from bench to bedside in the context of cancer immunotherapy.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pidgeon, Reilly C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2022-23) | Canada Spends